tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CDTX is currently covered by 4 analysts with an average price target of $18.87. This is a potential upside of $5.26 (38.65%) from yesterday's end of day stock price of $13.61.
Cidara Therapeutics's activity chart (see below) currently has 15 price targets and 29 ratings on display. The stock rating distribution of CDTX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 42.14% with an average time for these price targets to be met of 180.4 days.
Highest price target for CDTX is $25, Lowest price target is $6, average price target is $18.87.
Most recent stock forecast was given by LOUISE CHEN from CANTOR FITZGERALD on 25-Apr-2024. First documented stock forecast 11-May-2015.
Currently out of the existing stock ratings of CDTX, 17 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
11 days ago
2/3 (66.67%)
$3.96 (380.77%)
339
Buy
25
$12.49 (99.84%)
3
11 days ago
5/6 (83.33%)
$12 (92.31%)
285
Buy
6
$-6.51 (-52.04%)
6
28 days ago
5/7 (71.43%)
$4.93 (460.75%)
326
Buy
2 years 22 days ago
1/1 (100%)
$-2.15 (-14.19%)
158
Buy
8
2 years 22 days ago
0/3 (0%)
$6.41 (284.34%)
What is CDTX (Cidara Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CDTX (Cidara Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CDTX (Cidara Therapeutics)?
Which analyst is the currently most bullish on CDTX (Cidara Therapeutics)?
Which analyst is the currently most reserved on CDTX (Cidara Therapeutics)?
